BNGO Bionano Genomics, Inc. Company Net Income

BNGO (bionanogenomics.com) - company brandmark

Bionano Genomics, Inc. (BNGO) is implementing a genome optical mapping standard to identify hidden structural DNA variations. A chart of the company's net income is available in the GURU.Markets terminal, where the parameter has stabilized at -0.03. The business relies on the Saphyr closed-loop system featuring AI analysis and proprietary chips. Management is currently cutting costs, focusing on organic growth in system utilization without external expansion.

BNGO - Bionano Genomics Net Profit over the range 07/04/2022 - 11/01/2026

Analytical breakdowns and data insights for company bionanogenomics.com (BNGO)

- current quotes and average value forecast:
Market Chart Bionano Genomics|BNGO - Price Target Chart
- market capitalization data:
Market Value Bionano Genomics|BNGO - Total Company Value
- balance sheet equity data:
Equity per Share Bionano Genomics|BNGO - Book Capitalization|Market Capitalization to Book Value Ratio bionanogenomics.com|BNGO - Aggregate Company Assets
- debt and liquidity details:
Debt to Equity Ratio Bionano Genomics, Inc.|BNGO - Long-Term Debt to Equity|Current Liabilities to Capital Bionano Genomics|BNGO - Company Total Debt|Debt to Net Assets Ratio Bionano Genomics|BNGO - Company Long-Term Debts|Short-Term Indebtedness Bionano Genomics|Immediate Liquidity bionanogenomics.com
- earnings and market ratios statistics:
BNGO - Company Net Income
Summary company analysis:Bionano (BNGO)
Brand item of Bionano Genomics, Inc.

This indicator tracks daily financial results, allowing investors to monitor the real-time market adaptation of Bionano Genomics, Inc. (BNGO) without waiting for quarterly reports. The net operating profit trend aggregates actual cash flows, reflecting the commercial efficiency of the Saphyr genome mapping system, which provides unique diagnostics for complex structural DNA pathologies.

Direct competitors

TEM - Net Financial Result|Company Net Income Qiagen N.V.|Company Net Income ionispharma.com IONS|Company Net Income Repligen (RGEN)|Avidity Biosciences Inc - Company Profit|Net Profit CRSP (CRISPR Therapeutics Corp)|Net Profit GeneDx Corp WGS|RARE - Company Net Income|BEAM (beamtx.com) - Company Profit|Sarepta (SRPT) - Company Net Income|Company Net Income Twist Bioscience Inc (TWST)|Net Income TXG|NTLA: Final Profit|Net Profit STOK|biolifesolutions.com (BLFS) - Annual Net Income|Net Profit WVE (Wave Life Sciences Ltd.)|Maze Therapeutics, Inc. (MAZE) - Company Net Income|SION - Company Net Income|PRME (Prime Medicine Bio) - Company Profit|Taysha Gene Therapies (TSHA) - Company Net Income|Company Net Income uniqure.com (QURE)|Company Net Income MeiraGTx|Net Income REGENXBIO Inc (RGNX)|Net Profit SLDB|Net Financial Result Ocugen Pharma|Net Profit PACB (Pacific Biosciences)|BNTC - Net Income|DSGN - Company Net Income|Net Financial Result Rocket Pharma RCKT|FDMT (4D Molecular Therapeutics Inc) - Net Income|Lexeo Therapeutics, Inc. - Final Profit|KRRO (Korro Bio Inc.) - Net Profit|editasmedicine.com (EDIT) - Net Financial Result|Company Net Income Silence Therapeutics plc (SLN)|proqr.com - Company Profit|Net Profit CDXS (Codexis)|SGMO - Net Income|NAUT: Net Income|Net Financial Result metagenomi.co MGX|DTIL: Net Profit|GBIO (Generation Bio) - Company Net Income|Company Net Income Boundless Bio, Inc|Company Profit XCUR (Exicure Corp)|Net Profit IMNN|phiopharma.com (PHIO) - Annual Net Income|Company Net Income Mustang Bio MBIO|TransCode Therapeutics Inc. (RNAZ) - Company Net Income|Applied DNA - Net Profit|BLUE (bluebird bio, Inc) - Company Profit|immunoprecise.com (IPA) - Company Net Income|Company Profit OMGA|OMIC (Singular Genomics) - Net Profit|Net Profit Regulus Therapeutics, Inc.|Net Profit SYRS|Company Net Income TBIO (Telesis Bio, Inc)|Net Profit TCON (TRACON Pharmaceuticals)|Net Financial Result unitybiotechnology.com (UBX)